| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 989-998, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
S Bergese, R Pelletier, D Vallera, M Widmer and C Orosz
Department of Surgery, Ohio State University College of Medicine, Columbus, USA.
The in vivo mechanisms of vascular endothelial activation and VCAM-1 expression were studied in murine heterotopic cardiac grafts. Preliminary studies demonstrated that cardiac allograft endothelia develop reactivity with MECA-32 monoclonal antibody (MAb) and M/K-2 (anti-VCAM-1) MAb within 3 days of transplantation, whereas cardiac isografts develop MECA-32 reactivity but no M/K-2 reactivity. Additional studies demonstrated that a single treatment of cardiac isograft recipients with the anti-CD3 MAb 145-2C11 induces VCAM-1 expression on isograft microvascular endothelia within 24 hours. We have used this experimental system to identify the cytokines responsible for expression of VCAM-1 and MECA-32 MAb reactivity on graft vascular endothelia. We report that the expression of VCAM-1 on isograft endothelia that was induced with anti-CD3 MAb was blocked by simultaneous treatment with either pentoxifylline, soluble tumor necrosis factor (TNF) receptor (TNFR-Fc), anti-IL4 MAb, or soluble IL4R, but not by anti-IFN-gamma MAb. Alternatively, a similar pattern of isograft endothelial VCAM-1 expression was stimulated in the absence of anti-CD3 MAbs with a single injection of human recombinant TNF- alpha, or with recombinant murine IL4 provided as IL4/anti-IL4 MAb complexes. In addition, the IL4-induced VCAM-1 expression was completely blocked by a single intravenous treatment of the isograft recipients with TNFR:Fc. This suggests that high concentrations of TNF- alpha can stimulate endothelial VCAM-1 expression, but these concentrations are apparently not achieved in cardiac isografts. In the absence of an inducing agent such as anti-CD3 MAb, the stimulation of VCAM-1 expression with exogenous IL4 may reflect functional interaction between endogenous TNF and exogenous IL4, as suggested by the blocking experiments with TNFR:Fc. Although cardiac isograft endothelia normally develop reactivity with MECA-32 MAb within 3 days of transplantation, treatment of cardiac isograft recipients with anti-CD3 MAb accelerated MECA-32 reactivity to within 24 hours of transplantation. This accelerated expression can be experimentally manipulated in the same way as M/K-2 reactivity, suggesting that similar mechanisms may control the development of these two inflammatory endothelial phenotypical markers, despite their differential expression in cardiac isografts and allografts.
This article has been cited by other articles:
![]() |
G. C. Koo, K. Shah, G. J. F. Ding, J. Xiao, R. Wnek, G. Doherty, X. C. Tong, R. B. Pepinsky, K.-C. Lin, W. K. Hagmann, et al. A Small Molecule Very Late Antigen-4 Antagonist Can Inhibit Ovalbumin-induced Lung Inflammation Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1400 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A C S. Ventura and M Bohnke Pentoxifylline influences the autocrine function of organ cultured donor corneas and enhances endothelial cell survival Br. J. Ophthalmol., September 1, 2001; 85(9): 1110 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roque, J. T. Fallon, J. J. Badimon, W. X. Zhang, M. B. Taubman, and E. D. Reis Mouse Model of Femoral Artery Denudation Injury Associated With the Rapid Accumulation of Adhesion Molecules on the Luminal Surface and Recruitment of Neutrophils Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 335 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Sanz, L. Marinova-Mutafchieva, P. Green, R. R. Lobb, M. Feldmann, and S. Nourshargh IL-4-Induced Eosinophil Accumulation in Rat Skin Is Dependent on Endogenous TNF-{alpha} and {alpha}4 Integrin/VCAM-1 Adhesion Pathways J. Immunol., June 1, 1998; 160(11): 5637 - 5645. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |